Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis

European Respiratory Journal

Volumn 40, Issue 6, 2012, Pages 1468-1474

  Bonella, Francesco ^a   Bauer, Peter C ^a   Griese, Matthias ^b   Wessendorf, Thomas E ^a   Guzman, Josune ^c   Costabel, Ulrich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Alveolar proteinosis; Modified technique; Whole lung lavage

Indexed keywords

CARBON MONOXIDE; OXYGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DUST EXPOSURE; FEMALE; GERMANY; HUMAN; INTERMETHOD COMPARISON; KINETICS; LUNG ALVEOLUS PROTEINOSIS; LUNG DIFFUSION; LUNG FLUID; LUNG LAVAGE; LUNG VENTILATION; MALE; OXYGEN TENSION; PRIORITY JOURNAL; PROCEDURES; RELAPSE; SPECTROPHOTOMETRY; TREATMENT RESPONSE;

ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; DUST; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; KINETICS; LUNG; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; OXYGEN; PULMONARY ALVEOLAR PROTEINOSIS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SMOKING; SPECTROPHOTOMETRY; THERAPEUTIC IRRIGATION;

EID: 84871234711     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00017612     Document Type: Article

References (33)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-1142.
2. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215-235. (Pubitemid 34765459)
3. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177: 752-762. (Pubitemid 351490562)
4. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349: 2527-2539. (Pubitemid 38010079)
5. Huizar I, Kavuru MS. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management. Curr Opin PulmMed 2009; 15: 491-498.
6. Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol 2010; 135: 223-235.
7. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-880. (Pubitemid 29451632)
8. Costabel U, Guzman J. Pulmonary alveolar proteinosis: a new autoimmune disease. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: Suppl. 1, S67-S73. (Pubitemid 43166294)
9. Ramirez J, Schultz RB, Dutton RE. Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Arch Intern Med 1963; 112: 419-431.
10. Wasserman K, Blank N, Fletcher G. Lung lavage (alveolar washing) in alveolar proteinosis. Am J Med 1968; 44: 611-617.
11. Seard C, Wasserman K, Benfield JR, et al. Simultaneous bilateral lung lavage (alveolar washing) using partial cardiopulmonary bypass. Am Rev Respir Dis 1970; 101: 877-884.
12. Selecky PA, Wasserman K, Benfield JR, et al. The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: a ten-year experience. Ann Thorac Surg 1977; 24: 451-461. (Pubitemid 8227278)
13. Kavuru MS, Popovich M. Therapeutic whole lung lavage: a stopgap therapy for alveolar proteinosis. Chest 2002; 122: 1123-1124. (Pubitemid 35339519)
14. Morgan C The benefits of whole lung lavage in pulmonary alveolar proteinosis, Eur Respir J 2004; 23: 503-505. (Pubitemid 38455987)
15. Paschen C, Reiter K, Stanzel F, et al. Therapeutic lung lavages in children and adults. Respir Res 2005; 6: 138.
16. Cheng SL, Chang HT, Lau HP, et al. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest 2002; 122: 1480-1485.
17. Ioachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chron Respir Dis 2006; 3: 149-159. (Pubitemid 44221186)
18. Shah PL, Hansell D, Lawson PR, et al. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000; 55: 67-77. (Pubitemid 30248782)
19. Ramirez J. Bronchopulmonary lavage. New techniques and observations. Dis Chest 1966; 50: 581-588.
20. Hammon WE, McCaffree DR, Cucchiara AJ. A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest 1993; 103: 1409-1412. (Pubitemid 23145593)
21. Rodi G, Iotti G, Galbusera C, et al. Whole lung lavage. Monaldi Arch Chest Dis 1995; 50: 64-66.
22. Bingisser R, Kaplan V, Zollinger A, et al. Whole-lung lavage in alveolar proteinosis by a modified lavage technique. Chest 1998; 113: 1718-1719. (Pubitemid 28307185)
23. Perez A, Rogers RM. Enhanced alveolar clearance with chest percussion therapy and positional changes during whole-lung lavage for alveolar proteinosis. Chest 2004; 125: 2351-2356. (Pubitemid 38788209)
24. Onodera T, Nakamura M, Sato T, et al. Biochemical characterization of pulmonary washings of patients with alveolar proteinosis, interstitial pneumonitis and alveolar cell carcinoma. Tohoku J Exp Med 1983; 139: 245-263. (Pubitemid 13089240)
25. Alberti A, Luisetti M, Braschi A, et al. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med 1996; 154: 817-820. (Pubitemid 26327311)
26. Bonella FCM, Ohshimo S, Bavee PC, et al. Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis. Eur Respir J 2009; 34: A4674.
27. Latzin P, Tredano M, Wust Y, et al. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Thorax 2005; 60: 39-44. (Pubitemid 40101016)
28. Uchida K, Nakata K, Suzuki T, et al. Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 2009; 113: 2547-2456.
29. Takahashi T, Munakata M, Suzuki I, et al. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998; 158: 1294-1298. (Pubitemid 28489035)
30. Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004; 23: 526-531. (Pubitemid 38455992)
31. Seymour JF, Doyle IR, Nakata K, et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax 2003; 58: 252-257. (Pubitemid 36308005)
32. Lin FC, Chen YC, Chang SC. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis. Mayo Clin Proc 2008; 83: 1344-1349.
33. Ceruti M, Rodi G, Stella GM, et al. Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Orphanet J Rare Dis 2007; 2: 14.